A lung cancer drug that could save or extend the lives of 1000 Australians will have its cost slashed in the new year going from $90,000 per year to as low as $6.60 per script.
Liberal MP Craig Kelly said a small handful of bureaucrats in Australia are “ignoring the evidence” and denying Australians access to a medicine which all around the world is “shown to be saving lives”.
The federal government has secured a promising vaccine being developed at Oxford University after brokering a deal with a UK-based drug company.
Half a million Australians will tomorrow have access to cheaper medication, when 175 common prescription drugs are added to the PBS.
A personal story about the business of cancer research.